Overview
David Ebb is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Ebb is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Medulloblastoma, Glioma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.
His clinical research consists of co-authoring 60 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles and participated in 1 clinical trial in the study of Medulloblastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
Additional Areas of Focus
Dr. Ebb has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Mark Kieran is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Kieran is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. His top areas of expertise are Glioma, Brain Stem Cancer, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.
Susan Chi is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Chi is rated as a Distinguished provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Rhabdoid Tumor, Glioma, Medulloblastoma, and Brain Stem Cancer.
Pratiti Bandopadhayay is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Bandopadhayay is rated as an Advanced provider by MediFind in the treatment of Medulloblastoma. Her top areas of expertise are Glioma, Medulloblastoma, Brain Stem Cancer, and Embryonal Tumor with Multilayered Rosettes.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MedulloblastomaDr. Ebb isDistinguished. Learn about Medulloblastoma.
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- GliomaDr. Ebb isAdvanced. Learn about Glioma.
- OsteosarcomaDr. Ebb isAdvanced. Learn about Osteosarcoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Ebb isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Ewing SarcomaDr. Ebb isExperienced. Learn about Ewing Sarcoma.
- Infantile NeutropeniaDr. Ebb isExperienced. Learn about Infantile Neutropenia.
- NeuroblastomaDr. Ebb isExperienced. Learn about Neuroblastoma.
- Pediatric Low-Grade Glioma (pLGG)Dr. Ebb isExperienced. Learn about Pediatric Low-Grade Glioma (pLGG).
- RhabdomyosarcomaDr. Ebb isExperienced. Learn about Rhabdomyosarcoma.